Event-Driven Stocks

Orchestra BioMed Holdings, Inc.

OBIONasdaq

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$33.5M$2.6M$2.8M$3.5M——
Operating income−$51.8M−$64.3M−$51.5M−$32.7M−$394,756−$179,986
Net income−$52.7M−$61.0M−$49.1M−$33.6M−$378,753−$173,542
Total assets$114.9M$76.2M$95.2M$95.6M$161.8M$162.2M
Total liabilities$51.5M$43.2M$27.2M$43.0M$5.8M$5.7M
Equity$53.6M$33.0M$68.0M−$6.9M−$3.9M−$3.6M
EPS (diluted)$-1.11$-1.66$-1.48$-2.24$-0.02—
Shares out.38.3M35.8M11.2M20.4M20.4M4.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−154.7%
Net margin
−157.4%
Return on equity
−98.4%
Return on assets
−45.9%
Return on capital (ROCE)
−52.8%
Liabilities / assets
44.8%
Debt / equity
0.96×
Book value / share
$1.40
Revenue growth (YoY)
1169.2%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-7.02distress
Accruals / assets
−3.3%clean
Beneish M-Score
7.00elevated
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
62
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 3 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026842,2943.2-13.4%
Apr 30, 2026972,5905.1+9.7%
Apr 15, 2026886,6337.5-7.4%
Mar 31, 2026957,9394.0+20.6%
Mar 13, 2026794,5023.2-0.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.